BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12497777)

  • 1. [Selection criteria in the treatment of arterial hypertension and recommended guidelines].
    Agabiti-Rosei E; Muiesan ML; Bettoni G
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):527-32. PubMed ID: 12497777
    [No Abstract]   [Full Text] [Related]  

  • 2. Considerations in the treatment of mild-to-moderate hypertension.
    Giaquinta D
    Manag Care Interface; 2001 Mar; 14(3):80-1. PubMed ID: 11301960
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug committees welcome the SBU hypertension report. A number of patients can be offered cost-effective, evidence-based therapy].
    Ohlsson O
    Lakartidningen; 2004 Dec; 101(49):3984-5. PubMed ID: 15633336
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blockers and the treatment of hypertension.
    Williams B
    J Hypertens; 2007 Jul; 25(7):1351-3. PubMed ID: 17563554
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting.
    Amira CO; Okubadejo NU
    J Hum Hypertens; 2006 Nov; 20(11):894-7. PubMed ID: 16915299
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based treatment of hypertension. JNC 7 Guidelines provide an updated framework.
    Lookinland S; Beckstrand RL
    Adv Nurse Pract; 2003 Sep; 11(9):32-9; quiz 39-40. PubMed ID: 14521107
    [No Abstract]   [Full Text] [Related]  

  • 7. [New treatment strategies for the management of hypertension].
    Reinhardt A; Linsel-Nitschke P; Schunkert H
    MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
    [No Abstract]   [Full Text] [Related]  

  • 8. Out-of-pocket costs to users: medicine options for hypertension.
    Arredondo A
    Am J Hypertens; 2008 May; 21(5):492. PubMed ID: 18437138
    [No Abstract]   [Full Text] [Related]  

  • 9. [Minimal doses of drugs in hypertension].
    Robles NR
    Nefrologia; 2006; 26(1):10-5. PubMed ID: 16649421
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological cost-efficacy of various schemes of combined antihypertensive therapy in elderly patients].
    Red'kin IuV; Nikolaev NA
    Ter Arkh; 2005; 77(4):62-6. PubMed ID: 15938536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Costs vs. benefit: How much combination therapy of pulmonary arterial hypertension can we afford to pay?].
    GrĂ¼nig E
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S176. PubMed ID: 19718610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacoeconomic issues in antihypertensive treatment].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():271-5. PubMed ID: 16981554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thiazides--a first choice against high blood pressure].
    Meland E
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1876-7. PubMed ID: 19844281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of arterial hypertension].
    Tepel M
    Internist (Berl); 1999 Dec; 40(12):1334-6. PubMed ID: 10642922
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of hypertension 1996. Effectiveness, tolerance, cost-benefit aspects].
    Rahn KH
    Med Klin (Munich); 1996 Jun; 91(6):380-3. PubMed ID: 8767312
    [No Abstract]   [Full Text] [Related]  

  • 16. [Care in hypertension: guidelines and sources of error].
    Simon G
    Orv Hetil; 2005 May; 146(18):849-52. PubMed ID: 15926631
    [No Abstract]   [Full Text] [Related]  

  • 17. An economic evaluation of the 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of mild-to-moderate hypertension in Greece.
    Stafilas PC; Sarafidis PA; Lasaridis AN; Aletras VH; Niakas DA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1233-40; discussion 1241-2. PubMed ID: 16182115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies between use of antihypertensive drugs and guidelines indications: pharmacoeconomic implications.
    Robbiano L; Martelli A; Brambilla G
    J Hum Hypertens; 2005 Oct; 19(10):819-22. PubMed ID: 15951739
    [No Abstract]   [Full Text] [Related]  

  • 19. [German Hypertension League update. What does the ALLHAT Study really mean?].
    MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Practical guide-lines for the treatment of hypertension].
    Kiss I; Farsang C
    Orv Hetil; 2005 Feb; 146(6):267-74. PubMed ID: 15779815
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.